SSRIS AND TRICYCLICS

The levels of the tricyclic antidepressants can be raised by the SSRIs, but the extent varies greatly, from 20% to 10-fold. Tricyclic toxicity has been seen in a number of cases. Tricyclics may increase the levels of citalopram and possibly fluvoxamine, but the significance of this is unclear. There are several case reports of the serotonin syndrome, following concurrent and even sequential use of the SSRIs and tricyclics.
The increased tricyclic antidepressant levels can be beneficial. However, it has been suggested that patients given fluoxetine should have their tricyclic dose reduced to a quarter. Similar recommendations have been made with fluvoxamine (reduction in tricyclic dose to one-third) and sertraline. It would also seem prudent to consider a dosage reduction of the tricyclic if paroxetine is added. Some suggest that a small initial dose of the SSRI should also be used. Patients taking any combination of tricyclic and SSRI should be monitored for adverse effects (e.g. dry mouth, sedation, confusion) with tricyclic levels monitored where possible. Note that the active metabolite of fluoxetine has a half-life of 7 to 15 days, and so any interaction may persist for some time after the fluoxetine is withdrawn, and may therefore occur on sequential use.
(16)
This site is intended for general information only. The information provided on this site does not constitute medical advice and should not be relied upon. You should not act or refrain from acting on any legal or medical matter based on the content of this site.
© 2006-2025 medpill.info Last Updated On: 06/14/2025 (0)
×
Wait 20 seconds...!!!